TuesdayApr 02, 2019 11:58 am

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF) Receives Second Organic Certification; Gains Initial Approval on Hamilton Facility

TGOD recently received its second organic certification at its Hamilton facility Jefferies and Seaport Global have initiated coverage on the company’s stock TGOD’s Canada-listed shares climbed by more than 19 percent between February 28 and March 28, 2019 Company has received initial approval to operate a cannabis greenhouse in Ancaster, Ontario The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) is now most definitely on the radar of the investment community. In February, NYC-based investment bank Jefferies initiated coverage of the stock with a ‘Buy’ recommendation (http://cnw.fm/7ZOHz). The company’s stock price has been climbing in the wake of this…

Continue Reading

TuesdayApr 02, 2019 11:11 am

Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Set to Thrive within Blossoming Cosmeceutical Industry

Therma Bright Inc.’s proprietary technology has received Class II medical device status from the U.S. Food and Drug Administration The global market for cosmeceuticals was valued at nearly $47 billion in 2017 and is estimated to see continued growth The company is waiting on regulatory approvals for its thermal therapy technology, which incorporates the use of cannabis or cannabidiol Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF), a medical device technology provider focused on addressing dermatological needs in the multi-billion-dollar cosmeceutical (the convergence of cosmetic and pharmaceutical products) industry, offers relief for insect and marine life bites and stings, which is…

Continue Reading

MondayApr 01, 2019 1:27 pm

Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Readies Online Sales Strategy for New InterceptCS Cold Sore Prevention Device

THRBF offers an IoT- and Bluetooth-enabled device for cold-sore prevention Its sales strategy is part of the company’s larger focus on developing products for the dermatology market THRBF’s proprietary technology is designed to prevent cold sores in the OTC sector, which is projected to record significant sales growth Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) is offering a new generation of technology in the burgeoning skin care market. The company is specifically planning to target sales growth for its high gross-margin InterceptCS* cold sore prevention device with a new website, social media campaign and online sales strategy (http://cnw.fm/7Ahvq). THRBF’s new InterceptCS…

Continue Reading

MondayApr 01, 2019 12:58 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Launches Its Largest Cannabinoid Research Program

The R&D program will focus on the proprietary Lexaria DehydraTECH delivery technology with the purpose of enhancing it further Results could contribute to new patent filings in the future; in addition, the program will examine more extensively the way DehydraTECH-enabled CBD outperforms generic CBD Lexaria-designed nanotech enhancements will also be included in the program Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is launching its largest cannabinoid research and development program to date. The program consists of 11 separate animal studies, according to a company press release (http://cnw.fm/YZd5X). The Lexaria in vitro study design was…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977